Variant report
Variant | esv1010089 |
---|---|
Chromosome Location | chr6:118451929-118455014 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:118453596..118455211-chr6:118457163..118459104,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185432043 | chr6:118453452-118453453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190747263 | chr6:118453474-118453475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368498561 | chr6:118453483-118453484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140812974 | chr6:118453485-118453486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540572150 | chr6:118453506-118453507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192253957 | chr6:118453584-118453585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199733544 | chr6:118453585-118453586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35339665 | chr6:118453592-118453593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541592421 | chr6:118453639-118453640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563067264 | chr6:118453642-118453643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4945612 | chr6:118453643-118453644 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs150086235 | chr6:118453663-118453664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563917540 | chr6:118453690-118453691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570015473 | chr6:118453730-118453731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs74875745 | chr6:118453731-118453732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184639351 | chr6:118453824-118453825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149319342 | chr6:118453832-118453833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143565498 | chr6:118453934-118453935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573783649 | chr6:118453938-118453939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548751659 | chr6:118453994-118453995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11153724 | chr6:118454026-118454027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs537137758 | chr6:118454043-118454044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571272777 | chr6:118454067-118454068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552585982 | chr6:118454072-118454073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35732343 | chr6:118454077-118454078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570733094 | chr6:118454078-118454079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534637518 | chr6:118454100-118454101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563129759 | chr6:118454108-118454109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552867703 | chr6:118454121-118454122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188303935 | chr6:118454143-118454144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545702728 | chr6:118454182-118454183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535273688 | chr6:118454214-118454215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112978342 | chr6:118454301-118454302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564359310 | chr6:118454401-118454402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181121545 | chr6:118454496-118454497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575339245 | chr6:118454499-118454500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138133486 | chr6:118454500-118454501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564142538 | chr6:118454568-118454569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546609554 | chr6:118454713-118454714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539653062 | chr6:118454728-118454729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11759870 | chr6:118454741-118454742 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs78152970 | chr6:118454749-118454750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34069698 | chr6:118454775-118454776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147274867 | chr6:118454777-118454778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548838147 | chr6:118454827-118454828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140768723 | chr6:118454879-118454880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531060039 | chr6:118454938-118454939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78006819 | chr6:118454968-118454969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570893086 | chr6:118454977-118454978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534721364 | chr6:118455000-118455001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:118453400-118456800 | Enhancers | Fetal Lung | lung |
2 | chr6:118454000-118454200 | Enhancers | Brain Germinal Matrix | brain |
3 | chr6:118454000-118454600 | Enhancers | Fetal Kidney | kidney |
4 | chr6:118454000-118457200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr6:118454000-118457400 | Enhancers | Fetal Stomach | stomach |
6 | chr6:118454000-118460200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr6:118454200-118454400 | Enhancers | Brain Anterior Caudate | brain |
8 | chr6:118454200-118455200 | Weak transcription | Brain Germinal Matrix | brain |
9 | chr6:118454200-118457200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr6:118454400-118455400 | Weak transcription | Brain Anterior Caudate | brain |
11 | chr6:118454600-118455000 | Weak transcription | Fetal Kidney | kidney |
12 | chr6:118455000-118455800 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
13 | chr6:118455000-118455800 | Enhancers | Right Atrium | heart |
14 | chr6:118455000-118456000 | Enhancers | Left Ventricle | heart |
15 | chr6:118455000-118456400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr6:118455000-118456400 | Enhancers | Fetal Kidney | kidney |